Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Mertens Steve, Chief Technology Officer. Insider active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. Cumulatively, 36 reports have been recorded. History available since 3 February 2022. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mertens Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
252 shares@ US$1.611.2% of flowCommon StockSEC:0001772652-23-000011:0
25 of 36 declarations
About Mertens Steve
Mertens Steve is Directeur Technique at NEUROONE MEDICAL TECHNOLOGIES Corp, where he is also Chief Technology Officer. He has 36 filings in total, and the sampled filings cover the period from 2022-02-04 to 2026-04-01, with the most frequent transaction nature shown as Retenue fiscale.